RT
MRNA icon

Rockland Trust’s Moderna MRNA Stock Holding History

Rockland Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,779
Closed -$306K – 312
2022
Q1 		$306K Hold
1,779
– – 0.02% 268
2021
Q4 		$452K Sell
1,779
-7
-0.4% -$2.05K 0.03% 214
2021
Q3 		$687K Buy
1,786
+585
+49% +$216K 0.05% 173
2021
Q2 		$282K Buy
+1,201
New +$215K 0.02% 243

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rockland Trust's MRNA Position: Q2 2022 in Review

Rockland Trust sold out of Moderna (MRNA) in Q2 2022, closing a stake of 1,779 shares — an estimated $306K sold.

Rockland Trust first reported a position in MRNA in Q2 2021 and held it in 4 quarters. The position peaked at $687K in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Rockland Trust reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Rockland Trust sold 1,779 Moderna shares in Q2 2022, an estimated $306K.
  • Rockland Trust first reported a position in Moderna in Q2 2021 and held it in 4 quarters.
  • Rockland Trust's Moderna position peaked at $687K in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Rockland Trust's 13F filing for Q2 2022, filed 13 Jul 2022.